Browsing by Author Thollot, F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue DateViews
 
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial
Journal:Vaccine
Leung, TFLiu, APYLim, FSThollot, FOh, HMLLee, BWRombo, LTan, NCRouzier, RDe Simon, SSuryakiran, PHezareh, MThomas, FFolschweiller, NStruyf, F
2018
18
 
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial
Journal:Human Vaccines & Immunotherapeutics
Leung, TFLiu, APYLim, FSThollot, FOh, HMLee, BWRombo, LTan, NCRouzier, RFriel, DDe Muynck, BDe Simoni, SSuryakiran, PHezareh, MFolschweiller, NThomas, FStruyf, F
2015
134
 
Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24
Proceeding/Conference:Asia-Pacific Congress of Medical Virology, APCMV 2015
Liu, APYLeung, TFLim, FSThollot, FOh, HMLChan, PCLee, BWRombo, LTan, NCRouzier, RDe Simoni, SSuryakiran, PHezareh, MFolschweiller, NThomas, FStruyf, F
2015
69
 
Superiority of 2 doses of HPV-16/18 As04-adjuvanted vaccine versus 2 or 3 doses of HPV-6/11/16/18 vaccine: a randomised immunogenicity trial
Proceeding/Conference:International Papillomavirus Conference, HPV 2015
Rombo, LLeung, TFLiu, APYLim, FSThollot, FOh, HMLLee, BWTan, NCRouzier, RFriel, DDe Simoni, SSuryakiran, PHezareh, MFolschweiller, NThomas, FStruyf, F
2015
72
Showing results 1 to 4 of 4